US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

234.14

-2.5806-1.09%

Post-market: 234.480.3406+0.15%19:30 EDT

Volume:3K

Turnover:592.02K

Market Cap:469.80M

PE:- -

High:237.15

Open:236.66

Low:234.01

Close:236.72

52wk High:244.35

52wk Low:160.91

Shares:2.01M

Float Shares:2.01M

Volume Ratio:0.72

T/O Rate:0.13%

Dividend:0.95

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Vertex Minerals Revises Timeline for Proposed Securities Issue

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside

Political and General News Events from September 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

Revolution Medicines Director Lorence H. Kim Disposes of 17,090 Common Shares Worth USD 3.57 Million

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Champions Oncology Q1 Revenue Rises on Research Services Business

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BBH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":234.1394,"timestamp":1789761600000,"preClose":236.72,"halted":0,"volume":2519,"hourTrading":{"tag":"盘后","latestPrice":234.48,"preClose":234.1394,"latestTime":"19:30 EDT","volume":18,"amount":4208.8058,"timestamp":1789774205696,"change":0.3406,"changeRate":0.001455,"amplitude":0},"delay":0,"changeRate":-0.010901486988847601,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Market Closed","change":-2.5806,"latestTime":"09-18 16:00:00 EDT","open":236.66,"high":237.145,"low":234.01,"amount":592022.03016,"amplitude":0.013243,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":236.72,"sharesOutstanding":1976503,"nav":236.56399,"aum":498322764.45,"dividendRate":0.004048,"bidAskSpread":0.001072,"preHourTrading":{"tag":"盘前","latestPrice":236.72,"preClose":236.72,"latestTime":"04:00 EDT","volume":1,"amount":236.72,"timestamp":1789718407582,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":234.48,"preClose":234.1394,"latestTime":"19:30 EDT","volume":18,"amount":4208.8058,"timestamp":1789774205696,"change":0.3406,"changeRate":0.001455,"amplitude":0},"volumeRatio":0.7249337757599275,"impliedVol":0.1845,"impliedVolPercentile":0.3347},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7249337757599275,"shares":2006503,"dividePrice":0.9478,"high":237.145,"amplitude":0.013243,"preClose":236.72,"low":234.01,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":234.1394,"eps":0,"divideRate":0.004048,"volume":2519,"delay":0,"ttmEps":0,"open":236.66,"prevYearClose":189.2649,"prevWeekClose":229.3922,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":229.3922,"twentyDayClose":237.1125,"sixtyDayClose":194.9611},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667778666","title":"Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions","url":"https://stock-news.laohu8.com/highlight/detail?id=2667778666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667778666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBXU","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0058720904.USD","SG9999001440.SGD","BK4581","BK4588","IBBQ","LU0889565916.HKD","IE00BFTCPJ56.SGD","BIB","PBE","LU0109394709.USD","LU0122379950.USD","BK4139","LU0320765992.SGD","LU1983299246.USD","IE0009355771.USD","LU1057294990.SGD","BK4534","LU2112291526.USD","LU1023059063.AUD","IE00B2B36J28.USD","BK4533","LU2089984988.USD","BK4599","LU2242652126.USD","AMGN","BBH","LU1571399168.USD","IBB","IE00BJT1NW94.SGD","LU0289739699.SGD","IE0002141913.USD","LU2242646821.SGD","LU0868494617.USD","BK4566","LU2468319806.SGD","PJP","IE00B4R5TH58.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667774666","title":"Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4","url":"https://stock-news.laohu8.com/highlight/detail?id=2667774666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667774666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBE","LU0122379950.USD","LU2112291526.USD","BK4599","BK4585","LU2468319806.SGD","TBXU","LU2242652126.USD","BK4581","PJP","LU2242646821.SGD","IE00B2B36J28.USD","BK4534","IE00BFTCPJ56.SGD","AMGN","BK4139","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4533","LU0868494617.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4566","LU0109394709.USD","LU0320765992.SGD","LU1061106388.HKD","LU1057294990.SGD","LU0289739699.SGD","LU1983299246.USD","IE0009355771.USD","SG9999001440.SGD","BK4588","LU0058720904.USD","IE0002141913.USD","IBBQ","BIB","LU1023059063.AUD","LU1571399168.USD","BBH","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667701666","title":"FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®","url":"https://stock-news.laohu8.com/highlight/detail?id=2667701666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667701666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","IE00B2B36J28.USD","BK4533","TBXU","BK4588","LU1061106388.HKD","BIB","LU0889565916.HKD","LU1571399168.USD","LU0289739699.SGD","IE0002141913.USD","IBB","PJP","BK4534","SG9999001440.SGD","BK4566","LU0122379950.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IBBQ","IE0009355771.USD","LU1983299246.USD","LU0058720904.USD","LU0109394709.USD","BK4581","LU0320765992.SGD","LU2242652126.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4599","LU0868494617.USD","LU2089984988.USD","PBE","AMGN","BK4139","LU2112291526.USD","IE00BJT1NW94.SGD","BBH","BK4585","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667082666","title":"Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667082666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667082666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","LU2089984988.USD","LU2112291526.USD","BK4599","LU0289739699.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1061106388.HKD","IBB","BK4533","IE00BJT1NW94.SGD","LU1983299246.USD","LU0889565916.HKD","BK4588","BK4139","BK4585","LU1023059063.AUD","LU2242652126.USD","SG9999001440.SGD","BK4534","LU2242646821.SGD","TBXU","BIB","BK4566","IE00B2B36J28.USD","LU0109394709.USD","LU0122379950.USD","LU1057294990.SGD","LU0868494617.USD","IE00BFTCPJ56.SGD","BBH","LU0320765992.SGD","LU2468319806.SGD","PJP","PBE","IE0009355771.USD","IE0002141913.USD","AMGN","IBBQ","BK4581","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659991","title":"Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659991?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 4.3% to 5.48 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.The stock's rise snapped a three-day losing streak.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.86, which the company achieved Sept. 15.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.8% and Amgen Inc. remained unchanged.Trading volume totaled 72.9 million shares, compared to the 50-day average of 98.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK4566","LU2468319806.SGD","BIB","LU0289739699.SGD","IE0009355771.USD","BK4534","BK4599","LU1571399168.USD","SG9999001440.SGD","IE0002141913.USD","IBBQ","BK1515","IE00B4R5TH58.HKD","LU1061106388.HKD","LU2112291526.USD","BK4533","LU0320765992.SGD","IBB","BK4139","LU1983299246.USD","LU0889565916.HKD","BK4581","BK1191","BK4588","LU0109394709.USD","LU0868494617.USD","BK1521","LU2089984988.USD","LU2242646821.SGD","PBE","HK0000165453.HKD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BZ08YS42.EUR","LU1057294990.SGD","IE00BZ08YT58.USD","LU0058720904.USD","LU0122379950.USD","IE00B2B36J28.USD","01177","TBXU","LU1023059063.AUD","PJP","IE00BZ08YR35.GBP","BK4585","AMGN","BBH","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635488","title":"Vertex Minerals Revises Timeline for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635488?lang=en_us&edition=fundamental","pubTime":"2026-09-14 07:40","pubTimestamp":1789342824,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has provided an update. Vertex Minerals Ltd. has updated its proposed securities placement timetable, revising t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1674673428.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","BK4533","IE00B19Z9P08.USD","LU1674673691.USD","IE00B2B36J28.USD","BK4109","BK4588","TBXU","LU0061475181.USD","LU2362541273.HKD","IDNA","IE00B894F039.SGD","LU0256863811.USD","IE0009355771.USD","LU1585245621.USD","SG9999001176.SGD","LU1430594728.SGD","LU1815336091.USD","LU0417517546.SGD","BBH","IE00BJJMRZ35.SGD","VRTX","PBE","LU0079474960.USD","LU1093756325.SGD","GNMX","LU0757428866.USD","LU0109394709.USD","LU0234570918.USD","LU0320765992.SGD","LU2089984988.USD","IE00BZ9MQY76.HKD","VERX","MTX","SG9999001176.USD","IBBQ","BK4585","IE00B4R5TH58.HKD","LU0058720904.USD","LU0432979614.USD","LU1559883803.SGD","LU0566484027.USD","LU2468319806.SGD","LU0889565916.HKD","BK4532","BIB","IBB","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668081","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668081","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668081?lang=en_us&edition=fundamental","pubTime":"2026-09-14 01:20","pubTimestamp":1789320035,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Cooper Co (COO) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-cooper-co-coo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-cooper-co-coo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","IE0009354923.USD","RVMD","LABU","COO","CANC","XLV","IE00BJJMRZ35.SGD","BK4581","LU0320765992.SGD","IE0009355771.USD","LU2211815571.USD","LU0109394709.USD","BK4585","LU0889565916.HKD","LU2272731782.SGD","BK4137","HCSG","IE0002141913.USD","BK4139","PTH","BK4588","XBI","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4198","GB00BDT5M118.USD","LU1992135399.USD","BBH","IE00B2B36J28.USD","IDNA","LU0128526141.USD","IE00B4R5TH58.HKD","LU1992135472.HKD","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666509524","title":"Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2666509524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666509524?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:30","pubTimestamp":1789205400,"startTime":"0","endTime":"0","summary":"There is a strange paradox haunting healthcare investing right now.Heart disease remains humanity's top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make mon","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","IE00BJJMRX11.SGD","LU1814569148.SGD","LU0158827948.USD","LU2237443549.SGD","NVOH","IE00B4R5TH58.HKD","LLYZ","LU0345770993.USD","LU1571399168.USD","IE0002141913.USD","IE00BZ1G4Q59.USD","LU0787776722.HKD","TBXU","IE00BKPKM429.USD","LU1061106388.HKD","LU2491049909.HKD","LU0133085943.USD","LU2265009873.SGD","LU2168563687.JPY","LU1983299246.USD","SG9999018857.SGD","LU0466842654.USD","CANC","LU0198837287.USD","LU0234572021.USD","LU0868494617.USD","LU1023059063.AUD","LU0320765992.SGD","LU1291159041.SGD","LU0353189680.USD","IYH","LU1988902786.USD","04332","LU0203202063.USD","LU2023250330.USD","LU1720051017.SGD","LU1267930730.SGD","LU2111349929.HKD","LU2237438978.USD","LU2417539215.USD","OZEM","SG9999001176.USD","IE00BK4W5M84.HKD","LU1551013425.SGD","LU0256863811.USD","LU2361044949.HKD","SG9999014906.USD","BK4534","LU0672654240.SGD","LU0238689110.USD","LU2087625088.SGD","LU2063271972.USD","LU2168564222.USD","LU2023250504.SGD","LU2211815571.USD","LU0820561818.USD","SGXZ57979304.SGD","LU0208291251.USD","LU0943347566.SGD","LU1712237335.SGD","LU2602419157.SGD","IE00B2B36J28.USD","SG9999001440.SGD","LU1035775433.USD","SG9999015945.SGD","LU2491050154.USD","IE00BKDWB100.SGD","LU1145028129.USD","IE00B1BXHZ80.USD","THNR","BK4566","BK4532","LU2213496289.HKD","LU0097036916.USD","LU2462591350.SGD","IE00BK4W5L77.USD","LU2237443382.USD","LU2089984988.USD","SGXZ99366536.SGD","IE0005OL40V9.USD","LU0289739699.SGD","LU2271345857.HKD","LU2462157665.USD","BK4533","LU2756315318.SGD","LU0210536198.USD","SG9999014898.SGD","LU2461242641.AUD","SG9999013999.USD","LU0106261372.USD","LU1323610961.USD","LU2552382215.SGD","LU1280957306.USD","IBB","LU2237443895.HKD","AGNG","IE00BJLML261.HKD","LU0964807845.USD","LU0154236417.USD","LU0225283273.USD","LU2896262040.SGD","LU1868836757.USD","LU2242652126.USD","LU2468319806.SGD","IE0009355771.USD","GB00BDT5M118.USD","PBE","LU1069344957.HKD","GDOC","FHLC","SG9999015952.SGD","LU2471134523.USD","SG9999015978.USD","LU2361044865.SGD","LU2471134952.CNY","LU2108987350.USD","LLY","LU0823416689.USD","LU2237443978.SGD","LU0385154629.USD","LU1868836914.USD","LU1917777945.USD","IE00B1XK9C88.USD","LU2746668461.USD","LU1548497426.USD","LU0061475181.USD","LU0070302665.USD","IE0004445239.USD","LU1366192091.USD","LU2023251221.USD","LU2456880835.USD","BK4581","RXL","ELIL","IE00BFTCPJ56.SGD","CURE","LU1868837136.USD","LU2112291526.USD","IE00BFSS7M15.SGD","LU2237443622.USD","LU2242646821.SGD","BK4588","LU0471298777.SGD","IE00BJT1NW94.SGD","BBH","LU0058720904.USD","BIB","JDOC","LU0174119429.USD","LU2168564065.EUR","IE00BJJMRY28.SGD","LU0323591593.USD","LU2236285917.USD","LU0345770308.USD","LU1623119135.USD","SG9999001176.SGD","IHE","BK4007","LU2168564495.EUR","SG9999014880.SGD","XLV","NVOX","SG9999015986.USD","LU1232071149.USD","LU0320765489.SGD","TRUH","LU0354030438.USD","IBBQ","LU1093756168.USD","LU1093756325.SGD","LU1974910355.USD","LU0079474960.USD","LU0122379950.USD","LU0820561909.HKD","LU2089284900.SGD","LU1979441026.SGD","LU1720051108.HKD","MEDI","NVS","LU1064131342.USD","LU2552382132.HKD","LU1127390331.HKD","LU0114720955.EUR","LU1629891620.HKD","LU1551013342.USD","SGXZ51526630.SGD","LU0432979614.USD","LU0096364046.USD","LU0640476718.USD","LU2028103732.USD","LU2552382058.USD","SGXZ31699556.SGD","IE00BJJMRZ35.SGD","LU0823434583.USD","LU0823434740.USD","LU2106854487.HKD","BK4599","LU2471134879.HKD","TMED","LU0708995401.HKD","WDNA","LU2750360997.AUD","SGXZ81514606.USD","LLYX","ELIS","NVO","LU2168564149.EUR","LU0353189763.USD","LU2491050071.SGD","LU0882574055.USD","LU0109391861.USD","FTXH","LU0266013472.USD","LU2471134796.USD","IE00B4JS1V06.HKD","ILDR","IXJ","LU0256863902.USD","LU0094547139.USD","LLII","LU2324357040.USD","SG9999014914.USD","IE00BKVL7J92.USD","LU2756315664.SGD","HRTS","LU0456855351.SGD","VHT","SG9999018865.SGD","IE00B775H168.HKD","LU0320765059.SGD","LU0889565916.HKD","LU1868837300.USD","LU0820562030.AUD","BK4578","LU0354030511.USD","LU0109394709.USD","IE00BN29S564.USD","LU1868836591.USD","LU0158827781.USD","LU2264538146.SGD","LU0417517546.SGD","LU2360106947.USD","LU0786609619.USD","LU2089283258.USD","LU1804176565.USD","SG9999017495.SGD","IE0001KFT4U8.USD","BK4139","BK4585","LU0471298694.HKD","LU1057294990.SGD","PJP","IE00BFSS8Q28.SGD","AMGN","IE00BWXC8680.SGD","LU0211331839.USD","LU0689472784.USD","LU0882574139.USD","LU1989771016.USD","IE0004445015.USD","PPH","LU2361045086.USD","LU0203201768.USD","LU0683600562.USD","IE00B7KXQ091.USD","LU1691799644.USD","MHIP","LU0316494557.USD","LU2746668974.SGD","LU2357305700.SGD","NVOC","LU0006306889.USD","BK4516","LU2750360641.GBP","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666506002","title":"Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666506002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666506002?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:01","pubTimestamp":1789203667,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($PANW) ), ( ($ETN) ), ( ($AMGN) ), ( ($SPCX) ) and ( ($LMT) ). Here is a breakdown of their recent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/palo-alto-eaton-amgen-spacex-lmt-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/palo-alto-eaton-amgen-spacex-lmt-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPA","PBE","BBH","FOWF","IBB","ORBX","SPCH","AMGN","BK4516","IDEF","LMT","MARS","SPAX","WSPC","XOVL","LU0889565916.HKD","WDGF","DXYZ","TBXU","SPCF","PJP","DIPR","SPCU","WARP","LU1162221912.USD","BIB","SPCG","XOVR","LU1861558580.USD","LMTL","SPCX","LU1244550577.SGD","IBBQ","MISL","DSPC","SPCQ","LU1861220033.SGD","ELOL","LOFD","SNK","YSPC","LMTS","SPCM","SPAL","LOFF","NATO","SSPC","UFO","LU1861559042.SGD","SHLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574557","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574557?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:35","pubTimestamp":1789158900,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  shed 1.34% to $377.35 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.86% to 7,656.98 and the Dow Jones Industrial Average  rising 0.98% to 52,573.29.This was the stock's fifth consecutive day of losses.Amgen Inc. closed 15.59% below its 52-week high of $447.03, which the company achieved on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 0.29% to $265.58, Pfizer Inc.  rose 0.25% to $27.72, and AbbVie Inc.  rose 0.83% to $257.12.Trading volume  remained 337,805 below its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","BK4588","04332","IBB","IE00B2B36J28.USD","BK4585","BK4533","BK4581","IBBQ","IE0002141913.USD","BK4566","LU0868494617.USD","LU1023059063.AUD","LU0320765992.SGD","LU2089984988.USD","PBE","LU1057294990.SGD","LU1983299246.USD","LU0289739699.SGD","LU2112291526.USD","SG9999001440.SGD","LU2242646821.SGD","LU0109394709.USD","PJP","IE0009355771.USD","LU2468319806.SGD","BK4534","TBXU","LU0058720904.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2242652126.USD","BBH","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","AMGN","LU0889565916.HKD","LU1571399168.USD","BK4599","BK4139","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574302","title":"Moderna Inc. Stock Rallies 5.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574302?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 5.4% to $143.97 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 26,333.04 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.This was the stock's second consecutive day of gains.Moderna Inc. closed 18.5% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.3% to $265.58, Pfizer Inc. rose 0.3% to $27.72, and Gilead Sciences Inc. fell 0.75% to $143.72.Trading volume totaled 15.3 million, compared to the 50-day average of 17.4 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LGHT","IE00B3T34201.USD","LU1674673691.USD","BK4139","LU1571399168.USD","BK4578","MEDI","MRNX","BK4568","LU0114720955.EUR","LU0965509283.SGD","BK4534","BK4548","LU0861579265.USD","LU0965509010.AUD","TMED","LU0889565916.HKD","LU0289739699.SGD","BK4588","SG9999015978.USD","IE00B19Z3581.USD","LU1066051498.USD","LU0965509101.SGD","LU1674673428.USD","BMED","LU0965508806.USD","SG9999015952.SGD","MRNY","IBBQ","LU1778281490.HKD","LU0109394709.USD","LU0058720904.USD","LU2357627491.SGD","LU2468319806.SGD","WDNA","TBXU","LU1057294990.SGD","BIB","LU1585245621.USD","MRNA","GILD","SG9999015986.USD","GNOM","LU1934455277.USD","LU1430594728.SGD","IBB","IE00BSNM7G36.USD","IDNA","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257571","title":"Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257571","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257571?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:30","pubTimestamp":1789144234,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN), Sanofi ($SNYNF) announced an update on their ongoing clinical study. Regeneron (REGN) and Sanofi (SNYNF) have co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regeneron-and-sanofi-complete-key-dupilumab-itch-study-expanding-dermatology-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regeneron-and-sanofi-complete-key-dupilumab-itch-study-expanding-dermatology-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","TBXU","BK4585","LU2362541513.USD","LU0289739699.SGD","SNYNF","LU2468319806.SGD","LU0320765992.SGD","REGN","BK4139","BK4007","LU0823434740.USD","LU1974910355.USD","LU1917777945.USD","LU2362540622.SGD","LU0823434583.USD","LU2023250504.SGD","LU0058720904.USD","LU2106854487.HKD","LU0109394709.USD","IBBQ","LU2362541273.HKD","LU0882574055.USD","LU0114720955.EUR","LU2089984988.USD","LU2237438978.USD","BK4588","BBH","LU0053666078.USD","LU0823416689.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666240524","title":"Political and General News Events from September 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2666240524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666240524?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:34","pubTimestamp":1789130081,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from September 11Sept 11 (Reuters)-For other diaries, please see:Political and General NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4N4530Y8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00B4R5TH58.HKD","PJP","IE00BFTCPJ56.SGD","BK4599","LU2242646821.SGD","LU1061106388.HKD","BK4581","LU0320765992.SGD","LU0889565916.HKD","BK4139","BK4533","BK4534","BIB","LU0109394709.USD","LU1023059063.AUD","IBBQ","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2112291526.USD","LU1571399168.USD","TBXU","IE0002141913.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU2242652126.USD","AMGN","LU1983299246.USD","LU0122379950.USD","IE00B2B36J28.USD","SG9999001440.SGD","BK4566","BBH","LU0868494617.USD","BK4585","LU2468319806.SGD","BK4588","LU2089984988.USD","PBE","IE0009355771.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666546340","title":"Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2666546340","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666546340?lang=en_us&edition=fundamental","pubTime":"2026-09-11 13:57","pubTimestamp":1789106251,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) just unveiled an update. Vertex Minerals has amended its previously released updated mineral resource estimate f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-confirms-reward-gold-mine-resource-after-asxdriven-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-confirms-reward-gold-mine-resource-after-asxdriven-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4567","BK4532","BIB","LU1585245621.USD","VERX","BK4588","IE00B2B36J28.USD","IBB","LU2462157665.USD","BK4585","BK4533","LU2362541273.HKD","IBBQ","IE0002141913.USD","LU0256863811.USD","SGDJ","SG9999001176.SGD","LU0320765992.SGD","LU1778281490.HKD","LU1815336091.USD","PBE","SGXZ57979304.SGD","IDNA","LU2362540622.SGD","LU0109394709.USD","MTX","LU1035775433.USD","LU1093756325.SGD","LU2468319806.SGD","TBXU","BK4109","LU0058720904.USD","IE00B19Z3B42.SGD","GNMX","IE00BZ9MQY76.HKD","LU1559883803.SGD","IE00B19Z9P08.USD","VRTX","BBH","LU2456880835.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU2237438978.USD","LU2362541513.USD","IE00B19Z9Z06.USD","LU0889565916.HKD","LU2417539215.USD","LU2236285917.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516010","title":"Revolution Medicines Director Lorence H. Kim Disposes of 17,090 Common Shares Worth USD 3.57 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516010","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516010?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:53","pubTimestamp":1789077203,"startTime":"0","endTime":"0","summary":"Revolution Medicines director Lorence H. Kim disposes of 17,090 common shares worth USD 3.57 millionDirector Lorence H. Kim disclosed sales of 17,090 Revolution Medicines common shares on Sep. 8, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL1wDHJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Director Lorence H. Kim Disposes of 17,090 Common Shares Worth USD 3.57 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BBH","IE00B4R5TH58.HKD","IE0009354923.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","PTH","IE00BJJMRZ35.SGD","CANC","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4139","IE0009355771.USD","RVMD","IDNA","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515515","title":"Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515515","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:16","pubTimestamp":1789071415,"startTime":"0","endTime":"0","summary":"Vertex Pharma EVP Jasper van Grunsven files initial beneficial ownership statementVertex Pharmaceuticals EVP Jasper van Grunsven filed an initial Form 3 insider ownership statement dated Sept. 8, 2026","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL2ylbPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","IBB","TBXU","IE00BFTCPJ56.SGD","BK4585","LU0061475181.USD","LU0889565916.HKD","SGXZ57979304.SGD","LU1035775433.USD","IE0002141913.USD","IE00B2B36J28.USD","IE00B19Z3581.USD","LU0289739699.SGD","BK4533","BK4532","LU1069344957.HKD","LU2468319806.SGD","LU1674673428.USD","GNMX","VRTX","IE00B19Z9Z06.USD","LU0320765992.SGD","LU1093756168.USD","LU2362540622.SGD","PBE","LU2456880835.USD","IE0002270589.USD","LU0058720904.USD","SG9999001176.USD","LU2236285917.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","IBBQ","SG9999013999.USD","LU1674673691.USD","BIB","IE00B894F039.SGD","LU0432979614.USD","LU1430594728.SGD","LU2089984988.USD","IE0009355771.USD","IE00B19Z3B42.SGD","LU2237438978.USD","LU2417539215.USD","LU2324357040.USD","BBH","LU0256863811.USD","LU0823416689.USD","LU1585245621.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513067","title":"Champions Oncology Q1 Revenue Rises on Research Services Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513067","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513067?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071012,"startTime":"0","endTime":"0","summary":"Champions Oncology Q1 revenue rises on research services businessOverviewUS translational oncology research firm's fiscal Q1 revenue grew 8.8% yr/yrOncology services margin improved to 51% from 43% in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL1N45210N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1084165304.USD","IBB","LU0321505439.SGD","TBXU","LU1153584641.USD","LU0949170426.SGD","LU1267930573.SGD","LU0211327993.USD","LU2293690082.USD","LU1074936037.SGD","LU1261432733.SGD","LU3187612489.SGD","CSBR","AZN.UK","LU0827474353.SGD","LU1868836757.USD","LU1814569148.SGD","LU0640478417.SGD","LU0211328371.USD","LU1093756168.USD","LU2539964713.USD","PBE","LU2360032135.SGD","LU1119994496.HKD","LU1273509221.SGD","FTXH","LU0784384876.USD","BMY","LU0211326839.USD","IBBQ","PJP","BIB","03165","LU0096364046.USD","LU1430594728.SGD","LU0203345920.USD","LU0868494617.USD","LU2357627491.SGD","IHE","AMGN","BBH","LU0267386448.USD","LU0823416689.USD","LU1196032939.SGD","LU1355424745.HKD","LU0171276677.USD","LU1585245621.USD","LU1883839398.USD","LU1078025761.USD","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518829","title":"Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518829","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666518829?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:40","pubTimestamp":1789065600,"startTime":"0","endTime":"0","summary":"Revolution Medicines barely had time to celebrate the landmark approval of its pancreatic cancer pill before Wall Street demanded to know what's next.Late last month, regulators approved daraxonrasib ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","LU1585245621.USD","LU0114720955.EUR","LU1868837300.USD","LU0456855351.SGD","BK4588","BK4585","BK4581","IE00BSNM7G36.USD","LU1868836757.USD","IE0002141913.USD","PTH","LU0432979614.USD","LU0868494617.USD","IHE","LU1868836591.USD","LU1983299246.USD","FTXH","LU0985481810.HKD","LU1032466523.USD","IE00BFXG1179.USD","LU2125154935.USD","IDNA","LU0882574055.USD","BK4559","LU0109394709.USD","LU1718418525.SGD","LU1236620834.HKD","IE0009355771.USD","LU0267386448.USD","BK4534","LU1093756168.USD","LU0237698245.USD","LU1670711040.USD","LU2360032135.SGD","LU1571399168.USD","LU1670710588.SGD","BBH","CANC","LU0096364046.USD","LU2133065610.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0306806265.USD","BMY","LU0321505439.SGD","IE0009354923.USD","LU0321505868.SGD","LU1236620750.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666330597","title":"Amgen’s New Repatha Plaque Trial: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2666330597","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666330597?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:31","pubTimestamp":1789057881,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is launching a Phase 4 trial called “A Trial Assessing the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-new-repatha-plaque-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-new-repatha-plaque-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMGN","BK4581","PBE","IE0009355771.USD","LU1571399168.USD","ISBC","BK4139","SG9999001440.SGD","LU0058720904.USD","LU1057294990.SGD","LU1061106388.HKD","LU0289739699.SGD","LU0320765992.SGD","BK4566","BK4211","BK4533","BK4599","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4585","LU0109394709.USD","LU2242652126.USD","LU1983299246.USD","BIB","BK4534","IBBQ","LU2468319806.SGD","IE00B2B36J28.USD","BK4588","IE0002141913.USD","LU0122379950.USD","LU2242646821.SGD","LU1023059063.AUD","LU2089984988.USD","LU2112291526.USD","IBB","IE00BFTCPJ56.SGD","PJP","TBXU","IE00B4R5TH58.HKD","LU0889565916.HKD","LU0868494617.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666759267","title":"Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666759267","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666759267?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:57","pubTimestamp":1789055857,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals'  patent on Eylea HD is more likely to be retained, with the Patent Trial and Appeal Board, or PTAB, due to issue a final decision on an ongoing patent dispute by March 2027, RBC Capital Markets said in a Thursday note.The patent, which covers Eylea HD's formulation and method of treatment, was issued in 2024 and is set to expire May 10, 2039, according to the note. Alvotech  has challenged the patent, with the PTAB to hear arguments on Dec. 4 and issue a decision by March 3, 2027, the brokerage said.\"Our read and feedback suggests Regeneron is likely in a stronger position, particularly against Alvotech's prior art arguments,\" RBC said. The patent serves as the company's strongest defense for Eylea HD, blocking potential biosimilars, the investment firm noted.RBC has a sector perform rating on Regeneron Pharmaceuticals, with a $737 price target.Price: 795.00, Change: -12.65, Percent Change: -1.57","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0320765992.SGD","LU2362541513.USD","IBB","LU0053666078.USD","LU2362541273.HKD","TBXU","BBH","BK4139","LU2468319806.SGD","LU2362540622.SGD","LU2023250504.SGD","LU0889565916.HKD","LU0058720904.USD","BK4585","LU0823434740.USD","IBBQ","LU0882574055.USD","LU1974910355.USD","USRD","LU0109394709.USD","LU0823416689.USD","LU2106854487.HKD","LU2237438978.USD","LU0114720955.EUR","LU2089984988.USD","LU1917777945.USD","LU0289739699.SGD","LU0823434583.USD","REGN","ALVO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}